The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC).
 
Ayca Gucalp
No Relationships to Disclose
 
Tracy Ann Proverbs-Singh
No Relationships to Disclose
 
Adriana Corben
No Relationships to Disclose
 
Mary Ellen Moynahan
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
 
Sujata Patil
No Relationships to Disclose
 
Leigh Ann Boyle
No Relationships to Disclose
 
Clifford A. Hudis
Other Relationship - Breast Cancer Research Foundation
 
Tiffany A. Traina
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Genentech/Roche; Halozyme; Medivation; Mundipharma; Pfizer; Research to Practice
Research Funding - Eisai; Medivation; Novartis; Pfizer